Alpha Cognition (ACOGF) News Today → Thousands of investors use this no cost solution | Do you? (From Insider Financial) (Ad) Free ACOGF Stock Alerts C$0.49 0.00 (0.00%) (As of 04/24/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartHeadlinesStock AnalysisChartHeadlines All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAlpha Cognition Announces Fourth Quarter and Full Year 2023 Results and Provides Corporate Updatebusinesswire.com - April 3 at 10:08 PMPresenting on the Emerging Growth Conference 69 Day 1 on April 3 Register Nowfinance.yahoo.com - April 2 at 7:55 AMAlpha Cognition to Present at the Emerging Growth Conference on April 3, 2024 at 12:00pm EDT.businesswire.com - March 20 at 4:35 PMLife Science Virtual Investor Forum Agenda Announced for March 7th, 2024finance.yahoo.com - March 5 at 8:52 AMAlpha Cognition to Present at the Life Science Investor Forum March 7thfinance.yahoo.com - March 1 at 8:55 AMAlpha Cognition Files U.S. Patent Application Covering an ALPHA-1062 Oral Formulation to Treat Mild to Moderate Alzheimer's Diseasebusinesswire.com - February 22 at 8:30 AMAlpha Cognition Provides Business Updatefinance.yahoo.com - February 12 at 8:47 AMACOGF: Obtaining Capitalfinance.yahoo.com - February 6 at 5:11 PMACOGF: Full Year 2022 Financial Reportfinance.yahoo.com - February 6 at 5:11 PMAlpha Cognition Inc (ACOGF)nasdaq.com - December 29 at 8:38 PMAlpha Cognition Announces Fourth Closing of Private Placement and Continuation of the Offeringfinance.yahoo.com - December 22 at 6:18 PMFDA accepts Alpha Cognition’s NDA for Alzheimer’s diseasemsn.com - December 8 at 1:15 PMAlpha Cognition Announces FDA Acceptance of New Drug Application for ALPHA-1062 for Mild-to-Moderate Alzheimer's Diseasestockhouse.com - December 7 at 7:09 PMAlpha Cognition Announces FDA Acceptance of New Drug Application for ALPHA-1062 for Mild-to-Moderate Alzheimer’s Diseasefinance.yahoo.com - December 7 at 7:09 PMAlpha Cognition Announces Amended Terms of Private Placement and Continuation of the Offeringfinance.yahoo.com - December 4 at 10:27 PMAlpha Cognition Inc Ordinary Shares ACOGFmorningstar.com - November 14 at 5:49 PMAlpha Cognition Announces Third Closing of Private Placement and Continuation of the Offeringfinance.yahoo.com - November 8 at 5:44 PMCanadian Investment Regulatory Organization Trading Halt - ACOG.WTfinance.yahoo.com - October 2 at 8:30 PMAlpha Cognition Announces Submission of New Drug Application to the FDA for ALPHA-1062 for Mild-to-Moderate Alzheimer’s Diseasefinance.yahoo.com - September 27 at 5:50 PMWolfram Alpha, Meet ChatGPT: Stephen Wolfram Talks Intelligence And Large Language Modelsforbes.com - September 20 at 2:20 PMAlpha Cognition Announces Initial Closing of Private Placement and Pricing for Continuation of the Offeringfinance.yahoo.com - August 31 at 8:18 PMAlpha Cognition GAAP EPS of -$0.03msn.com - August 22 at 5:41 PMAlpha Cognition Announces Second Quarter and Six Months Ended 2023 Results and Provides Corporate Updatefinance.yahoo.com - August 22 at 5:41 PMAlpha Cognition Receives Notice of Allowance for U.S. Patent Application covering use of ALPHA-1062 for Mild to Moderate Alzheimer’s Diseasefinance.yahoo.com - August 14 at 8:45 PMACOGF - Alpha Cognition Inc.finance.yahoo.com - August 11 at 7:21 PMACOGF: Bioequivalence Completefinance.yahoo.com - October 18 at 11:51 AM Get Alpha Cognition News Delivered to You Automatically Sign up to receive the latest news and ratings for ACOGF and its competitors with MarketBeat's FREE daily newsletter. Email Address The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet. See how you can invest alongside him ACOGF Media Mentions By Week ACOGF Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ACOGF News Sentiment▼0.000.44▲Average Medical News Sentiment ACOGF News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ACOGF Articles This Week▼00▲ACOGF Articles Average Week Get Alpha Cognition News Delivered to You Automatically Sign up to receive the latest news and ratings for ACOGF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Autonomix Medical News Enzo Biochem News Reneo Pharmaceuticals News IceCure Medical News Sensus Healthcare News Gain Therapeutics News Kronos Bio News SCYNEXIS News Homology Medicines News AVROBIO News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTC:ACOGF) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”AltimetryExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersNew Trump BombshellThe Freeport Society1970’s computer coder issues shocking A.I. warningTradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alpha Cognition Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
